Fianlimab with cemiplimab for untreated unresectable advanced melanoma or adjuvant treatment of completely resected high-risk melanoma [TSID12303]

  • Awaiting development
  • GID-TA11929
  • Expected publication date: TBC

35012-Fianlimab-Cemiplimab-for-Melanoma-V1.0-OCT2025-NON-CONF.pdf